Clearmind Medicine (CMND) Share-based Compensation (2022 - 2026)

Clearmind Medicine (CMND) has reported Share-based Compensation for 5 consecutive years, with $131252.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 43.36% year-over-year to $131252.0; the trailing twelve-month figure through Apr 2026 stood at $1.7 million (up 35.09% YoY), and the FY2025 full-year result was $805890.0, down 19.32% from the prior year.
• Share-based Compensation slipped to $131252.0 in Q2 2026 per CMND's latest filing, from $1.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $1.4 million in Q1 2026 and bottomed at $34004.0 in Q1 2024.
• Historically, Share-based Compensation has averaged $298784.8 across 5 years, with a median of $231722.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation tumbled 82.65% in 2024, then jumped 1019.69% in 2025.
• Over 5 years, Share-based Compensation stood at $203213.0 in 2022, then jumped by 148.89% to $505781.0 in 2023, then tumbled by 41.17% to $297544.0 in 2024, then slumped by 61.14% to $115640.0 in 2025, then climbed by 13.5% to $131252.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $131252.0, $1.4 million, and $115640.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.